Physician profile
Luisa Vera
NPI 1710416219
$4,915.21
in general payments reported to CMS, 2019-2025
33 companies · $999 in 2025
The $999 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $1,336 · 2023: $1,290 · 2024: $969 · 2025: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,169 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,168.68 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $607.70 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $501.17 | 2022-2025 | |
| Pfizer INC. | $491.40 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $487.04 | 2022-2025 | |
| Evofem Biosciences, INC. | $274.66 | 2021-2025 | Phexxi, Solosec, Phexx |
| Abbvie INC. | $250.79 | 2022-2024 | Lo Loestrin Fe, Orilissa, Ubrelvy |
| Aspira Women'S Health INC | $186.69 | 2022-2024 | Ova1 |
| Biogen, INC. | $176.55 | 2024-2025 | Zurzuvae |
| Amgen INC. | $173.64 | 2022-2024 | Evenity, Prolia |
| Organon LLC | $162.33 | 2022-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $143.28 | 2023-2025 | Myfembree, Gemtesa |
| Sage Therapeutics, LLC | $140.71 | 2021-2023 | |
| Astellas Pharma Global Development | $139.55 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $111.89 | 2022-2025 | Slynd |
| Channel Medsystems, INC. | $101.87 | 2023-2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $97.49 | 2021-2022 | |
| Shield Therapeutics INC | $93.16 | 2022-2024 | Accrufer |
| Alydia Health | $91.49 | 2021 | |
| Myriad Women'S Health, INC. | $90.12 | 2023 | |
| Agile Therapeutics, INC. | $86.96 | 2021-2024 | Twirla |
| Scynexis, INC. | $79.41 | 2022 | |
| Coopersurgical, INC. | $63.13 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $54.31 | 2024-2025 | Acessa Provu System, Aptima, Myosure Tissue Removal Device |
| Baxter Healthcare | $53.78 | 2021-2022 | |
| Avion Pharmaceuticals | $46.50 | 2021-2022 | |
| Exact Sciences Corporation | $44.11 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $38.17 | 2025 | Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $37.19 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $24.46 | 2021 | |
| Dexcom, INC. | $23.53 | 2025 | Dexcom G6 Transmitter |
| Lsi Solutions INC | $16.05 | 2024 | Fornisee |
| Urovant Sciences INC | $13.97 | 2021 | |
| Therapeuticsmd, INC. | $12.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luisa Vera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.